Moderate hypofractionated radiotherapy vs conventional fractionated radiotherapy in localized prostate cancer: a systemic review and meta-analysis from Phase III randomized trials

PURPOSE: To determine the efficacy and late toxicities of moderate (2.5–4 Gy) hypofractionated radiotherapy (H-RT) in localized prostate cancer, a meta-analysis of published randomized clinical trials comparing moderate H-RT with conventional fractionated RT (C-RT) was performed. MATERIALS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Zhenzhen, You, Jinqiang, Wang, Youyou, Zhao, Jinlin, Jiang, Shengpeng, Zhang, Ximei, Wang, Peiguo, Tao, Zhen, Wang, Xin, Yuan, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388980/
https://www.ncbi.nlm.nih.gov/pubmed/30863093
http://dx.doi.org/10.2147/OTT.S181067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388980/
https://www.ncbi.nlm.nih.gov/pubmed/30863093
http://dx.doi.org/10.2147/OTT.S181067

Ejemplares similares